Does sympathetic hyperactivity adversely impact on the effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure?

Marcio Galindo Kiuchi; Shaojie Chen; Revathy Carnagarin; Humberto Villacorta; Markus Schlaich

doi:10.1093/europace/euz298

Does sympathetic hyperactivity adversely impact on the effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure?

Marcio Galindo Kiuchi, Shaojie Chen, Revathy Carnagarin, Humberto Villacorta, Markus Schlaich

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	euz298
Pages (from-to)	331
Number of pages	1
Journal	Europace
Volume	22
Issue number	2
DOIs	https://doi.org/10.1093/europace/euz298
Publication status	Published - 1 Feb 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/europace/euz298

Cite this

@article{45a14ad2695848bdaee4560f07dbdb05,

title = "Does sympathetic hyperactivity adversely impact on the effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure?",

author = "{Galindo Kiuchi}, Marcio and Shaojie Chen and Revathy Carnagarin and Humberto Villacorta and Markus Schlaich",

year = "2020",

month = feb,

day = "1",

doi = "10.1093/europace/euz298",

language = "English",

volume = "22",

pages = "331",

journal = "Europace",

issn = "1099-5129",